Avalo Therapeutics plans resale of 2,655 shares

Avalo Therapeutics (symbol AVTX) has filed a notice of proposed resale of 2,655 shares of common stock.

Rhea-AI Filing Summary

Avalo Therapeutics (symbol AVTX) has filed a notice of proposed resale of 2,655 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading routed on NASDAQ on or after August 11, 2026.

The shares were originally acquired on December 10, 2025 through an Employee Stock Purchase Plan for cash consideration.

Key Figures

Shares proposed for resale: 2,655 shares Acquisition date of shares: December 10, 2025 Proposed sale date: August 11, 2026 +1 more

4 metrics

Shares proposed for resale 2,655 shares Common stock covered by the Form 144 notice

Acquisition date of shares December 10, 2025 Date shares were purchased through Employee Stock Purchase Plan

Proposed sale date August 11, 2026 Date listed for proposed NASDAQ resale

Aggregate market value 52,012.25 Listed value associated with the 2,655 common shares

Key Terms

Form 144, Employee Stock Purchase Plan, Morgan Stanley Smith Barney LLC Executive Financial Services

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Employee Stock Purchase Plan financial

"Shares Purchased Through Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Morgan Stanley Smith Barney LLC Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AVTX Form 144 filing report?

It reports a proposed resale of 2,655 AVTX common shares. The shares were acquired through an Employee Stock Purchase Plan and are planned to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.

How many Avalo Therapeutics (AVTX) shares are covered by this Form 144?

The filing covers 2,655 shares of AVTX common stock. These shares were previously purchased through an Employee Stock Purchase Plan and are now being registered for possible resale.

When were the AVTX shares proposed for resale originally acquired?

The 2,655 AVTX shares were acquired on December 10, 2025. They were purchased for cash through an Employee Stock Purchase Plan, according to the Form 144 disclosure.

Through which broker will the AVTX Form 144 shares be sold?

The Form 144 lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The proposed sale of 2,655 AVTX common shares is expected to be executed via NASDAQ.

On which market is the AVTX Form 144 sale expected to occur?

The filing indicates that the 2,655 AVTX common shares are proposed to be sold on NASDAQ. The trades will be handled through Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:23 PM Accepted by SEC EDGAR 08/11/2026 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002047607
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AVALO THERAPEUTICS, INC.
SEC File Number	001-37590
Address of Issuer	1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PENNSYLVANIA 19087
Phone	410-522-8707
Name of Person for Whose Account the Securities are To Be Sold	JENNIFER RILEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2655	52012.25	53630000	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2025	Shares Purchased Through Employee Stock Purchase Plan	Issuer			2655	12/10/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Riley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)